Monsanto Company (MON) Downgraded by Vetr Inc.

Monsanto Company (NYSE:MON) was downgraded by stock analysts at Vetr from a “buy” rating to a “hold” rating in a report released on Monday. They currently have a $118.00 price target on the stock. Vetr‘s price objective points to a potential upside of 3.43% from the company’s previous close.

MON has been the subject of several other research reports. CLSA upgraded shares of Monsanto Company from an “underperform” rating to an “outperform” rating in a research report on Friday, January 6th. They noted that the move was a valuation call. Zacks Investment Research cut shares of Monsanto Company from a “buy” rating to a “hold” rating in a research report on Monday, January 9th. Royal Bank of Canada assumed coverage on shares of Monsanto Company in a research report on Thursday, February 23rd. They set a “sector perform” rating and a $118.00 price target for the company. Finally, Sanford C. Bernstein set a $105.00 price objective on shares of Monsanto Company and gave the stock a “neutral” rating in a research note on Thursday, January 5th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Monsanto Company currently has an average rating of “Buy” and an average target price of $116.15.

Analyst Recommendations for Monsanto Company (NYSE:MON)

Shares of Monsanto Company (NYSE:MON) traded up 0.37% on Monday, hitting $114.09. 2,367,071 shares of the stock traded hands. The firm has a market capitalization of $50.03 billion, a PE ratio of 31.28 and a beta of 0.93. The firm’s 50 day moving average is $111.98 and its 200 day moving average is $106.06. Monsanto Company has a 52 week low of $84.79 and a 52 week high of $116.04.

Monsanto Company (NYSE:MON) last issued its quarterly earnings results on Thursday, January 5th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.01 by $0.20. Monsanto Company had a net margin of 11.61% and a return on equity of 47.05%. The company earned $2.22 billion during the quarter. During the same quarter in the prior year, the firm earned ($0.11) EPS. The firm’s quarterly revenue was up 19.4% compared to the same quarter last year. On average, analysts expect that Monsanto Company will post $4.74 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, April 7th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.89%. The ex-dividend date is Wednesday, April 5th. Monsanto Company’s dividend payout ratio is presently 58.86%.

TRADEMARK VIOLATION WARNING: “Monsanto Company (MON) Downgraded by Vetr Inc.” was originally reported by Mideast Time and is owned by of Mideast Time. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.mideasttime.com/monsanto-company-mon-downgraded-by-vetr-inc/1589680.html.

In other news, EVP Steven Mizell sold 2,525 shares of the business’s stock in a transaction on Tuesday, January 10th. The shares were sold at an average price of $108.56, for a total value of $274,114.00. Following the sale, the executive vice president now owns 43,711 shares of the company’s stock, valued at $4,745,266.16. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Michael K. Stern sold 5,670 shares of the business’s stock in a transaction on Wednesday, January 25th. The stock was sold at an average price of $110.00, for a total transaction of $623,700.00. Following the completion of the sale, the chief executive officer now directly owns 20,534 shares in the company, valued at approximately $2,258,740. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Mascoma Wealth Management LLC acquired a new stake in shares of Monsanto Company during the fourth quarter worth approximately $115,000. JNBA Financial Advisors raised its stake in shares of Monsanto Company by 24.6% in the fourth quarter. JNBA Financial Advisors now owns 1,148 shares of the company’s stock worth $121,000 after buying an additional 227 shares in the last quarter. First Bank & Trust acquired a new stake in shares of Monsanto Company during the fourth quarter worth approximately $138,000. First Manhattan Co. raised its stake in shares of Monsanto Company by 5.6% in the third quarter. First Manhattan Co. now owns 1,369 shares of the company’s stock worth $139,000 after buying an additional 73 shares in the last quarter. Finally, Israel Discount Bank of New York GFN acquired a new stake in shares of Monsanto Company during the fourth quarter worth approximately $140,000. 75.18% of the stock is currently owned by institutional investors and hedge funds.

About Monsanto Company

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

To view Vetr’s full report, visit Vetr’s official website.

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.